AACR-PLGA Fund at the Pediatric Brain Tumor Foundation Research Grant to Optimize Drug Dosing Strategies for Pediatric LGA/LGG Patients

Funding Agency:
American Association for Cancer Research

The Pediatric Brain Tumor Foundation’s PLGA Fund and the AACR are proud to announce the inaugural Research Grant to Optimize Drug Dosing Strategies for Pediatric LGA/LGG Patients. This grant represents a joint effort to promote and support innovative and collaborative research focused on the most common forms of pediatric brain cancer – low grade glioma/astrocytoma. The research proposed for funding should be translational in nature (though basic science and clinical proposals will also be considered), and should be focused on improving the understanding and identification of effective dosing parameters for treating children with PLGA brain tumors, with indications for children battling other types of brain tumors. Proposals should also include at least one collaborator from an institution separate from the applicant’s institution.

Applications are invited from researchers in the field as well as investigators with experience in other areas of cancer or biomedical research who have promising ideas and approaches that can be applied to PLGA.

Projects must be implemented by a collaborative research team, composed of one principal investigator and at least one collaborator from different institutions. This grant provides $180,000 over two years for expenses related to the research project, which may include salary and benefits of the grant recipient and any collaborators, postdoctoral or clinical research fellows, graduate students and/or research assistants; research/laboratory supplies; equipment; travel; publication charges for manuscripts that pertain directly to the funded project; and other research expenses.

Deadline: Dec. 9, 2019

Agency Website

Eligibility Requirements

Applicants must have a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree. The project will be directed by the Principal Investigator (PI), who is responsible for the application, disbursement of funds to the project, the conduct of the project, and progress reporting. In addition, each project should include at least one collaborator from a separate institution from the PI's institution.

Applications will be accepted from independent investigators who are affiliated with an academic, medical, or research institution anywhere in the world.

Employees or subcontractors of a U.S. government entity or for-profit private industry are not eligible.  Employees or subcontractors of a U.S. government entity or for‐profit private industry may serve as Collaborators, but no grant funds may be directed towards these individuals.

Investigators may submit only one application for the AACR-PLGA Fund at the Pediatric Brain Tumor Foundation Research Grant to Optimize Drug Dosing Strategies for Pediatric LGA/LGG Patients but may concurrently apply for other AACR grants. However, applicants are expected to accept the first grant they are awarded. Individuals may accept and hold only one AACR grant at a time. Current AACR grantees are permitted to apply if they are in compliance with all progress and financial report requirements before the start of the grant term. 

Amount

$180,000

Funding Type

Award

Eligibility

Faculty

Category

Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

December 9, 2019